Przemysław Juszczyński
Przemysław Juszczyński
Instytut Hematologii i Transfuzjologii
Verified email at
Cited by
Cited by
Integrative analysis reveals selective 9p24. 1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and …
MR Green, S Monti, SJ Rodig, P Juszczynski, T Currie, E O'Donnell, ...
Blood, The Journal of the American Society of Hematology 116 (17), 3268-3277, 2010
Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy
MR Green, S Rodig, P Juszczynski, J Ouyang, P Sinha, E O'Donnell, ...
Clinical cancer research 18 (6), 1611-1618, 2012
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma
L Chen, S Monti, P Juszczynski, J Daley, W Chen, TE Witzig, ...
Blood, The Journal of the American Society of Hematology 111 (4), 2230-2237, 2008
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
P Juszczynski, J Ouyang, S Monti, SJ Rodig, K Takeyama, J Abramson, ...
Proceedings of the National Academy of Sciences 104 (32), 13134-13139, 2007
SYK inhibition modulates distinct PI3K/AKT-dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas
L Chen, S Monti, P Juszczynski, J Ouyang, B Chapuy, D Neuberg, ...
Cancer cell 23 (6), 826-838, 2013
BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate
P Juszczynski, JL Kutok, C Li, J Mitra, RCT Aguiar, MA Shipp
Molecular and cellular biology, 2006
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms
S Parekh, JM Polo, R Shaknovich, P Juszczynski, P Lev, SM Ranuncolo, ...
Blood, The Journal of the American Society of Hematology 110 (6), 2067-2074, 2007
BBAP monoubiquitylates histone H4 at lysine 91 and selectively modulates the DNA damage response
Q Yan, S Dutt, R Xu, K Graves, P Juszczynski, JP Manis, MA Shipp
Molecular cell 36 (1), 110-120, 2009
Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas
JM Polo, P Juszczynski, S Monti, L Cerchietti, K Ye, JM Greally, M Shipp, ...
Proceedings of the National Academy of Sciences 104 (9), 3207-3212, 2007
Protein tyrosine phosphatase receptor–type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell–receptor signaling, and cellular proliferation
L Chen, P Juszczynski, K Takeyama, RCT Aguiar, MA Shipp
Blood 108 (10), 3428-3433, 2006
Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome
P Juszczynski, E Kalinka, J Bienvenu, G Woszczek, M Borowiec, T Robak, ...
Blood, The Journal of the American Society of Hematology 100 (8), 3037-3040, 2002
FOXO1 transcription factor: a critical effector of the PI3K-AKT axis in B-cell development
M Szydłowski, E Jabłońska, P Juszczyński
International reviews of immunology 33 (2), 146-157, 2014
AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features
SJ Rodig, J Ouyang, P Juszczynski, T Currie, K Law, DS Neuberg, ...
Clinical Cancer Research 14 (11), 3338-3344, 2008
Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders
J Ouyang, P Juszczynski, SJ Rodig, MR Green, E O'Donnell, T Currie, ...
Blood, The Journal of the American Society of Hematology 117 (16), 4315-4322, 2011
FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas
M Szydlowski, P Kiliszek, T Sewastianik, E Jablonska, E Bialopiotrowicz, ...
Blood, The Journal of the American Society of Hematology 127 (6), 739-748, 2016
MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications
T Sewastianik, M Prochorec-Sobieszek, B Chapuy, P Juszczyński
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (2), 457-467, 2014
BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt
P Juszczynski, L Chen, E O'Donnell, JM Polo, SM Ranuncolo, ...
Blood, The Journal of the American Society of Hematology 114 (26), 5315-5321, 2009
Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy
D Komar, P Juszczynski
Clinical epigenetics 12, 1-14, 2020
Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma
M Szydłowski, M Prochorec-Sobieszek, A Szumera-Ciećkiewicz, ...
Blood, The Journal of the American Society of Hematology 130 (12), 1418-1429, 2017
MLL-Rearranged B Lymphoblastic Leukemias Selectively Express the Immunoregulatory Carbohydrate-Binding Protein Galectin-1
P Juszczynski, SJ Rodig, J Ouyang, E O'Donnell, K Takeyama, ...
Clinical Cancer Research 16 (7), 2122-2130, 2010
The system can't perform the operation now. Try again later.
Articles 1–20